Bleomycin delivery into cancer cells in vitro with ultrasound and SonoVue® or BR14® microbubbles

Journal of Drug Targeting

Volumn 21, Issue 4, 2013, Pages 407-414

  Lamanauskas, N ^a,b   Novell, A ^b   Escoffre, J M ^b   Venslauskas, M ^a   Satkauskas S ^a   Bouakaz, A ^b  

^a VYTAUTAS MAGNUS UNIVERSITY   (Lithuania)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Bleomycin; BR14; Microbubble; Sonodestruction; Sonoporation; SonoVue

Indexed keywords

BLEOMYCIN; SONOVUE;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HCT116; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBUBBLE; PRIORITY JOURNAL; ULTRASOUND;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; BLEOMYCIN; CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HCT116 CELLS; HUMANS; MICROBUBBLES; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; ULTRASONICS;

EID: 84877142221     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.761223     Document Type: Article

References (44)

1. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996;27:745-8.
2. Escoffre JM, Rols MP. Electrochemotherapy: progress and prospects. Curr Pharm 2012;18:3406-15.
3. Roy SN, Horwitz SB. Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. Cancer Res 1984;44:1541-6.
4. Lazo JS. Bleomycin. In: Chabner BA, ed. Cancer chemotherapy and biotherapy. Philadelphia (PA): Lippincott-Raven; 1996:379-93.
5. Pron G, Mahrour N, Orlowski S, et al. Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 1999;57:45-56.
6. Poddevin B, Orlowski S, Belehradek JJr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmac 1991;42:67-75.
7. Orlowski S, Belehradek JJr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotox-icity of anticancer drugs. Biochem Pharmac 1988;37:4727-33.
8. Satkauskas S, Batiuskaite D, Salomskaite-Davalgiene S, Venslauskas MS. Effectiveness of tumor electrochemotherapy as a function of electric pulse strength and duration. Bioelectrochemistry 2005;65:105-11.
9. Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy. EJC Supplements 2006;4:14-25.
10. Nomikou N, Li YS, McHale AP. Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. Cancer Lett 2010;288:94-8.
11. Escoffre JM, Kaddur K, Rols MP, Bouakaz A. In vitro gene transfer by electrosonoporation. Ultrasound Med Biol 2010;3:1746-55.
12. Yoon CS, Park JH. Ultrasound-mediated gene delivery. Expert Opin Drug Deliv 2010;7:321-30.
13. Zolochevska O, Figueiredo ML. Advances in sonoporation strategies for cancer. Front Biosci (Schol Ed) 2012;4:988-1006.
14. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997;23:953-9.
15. Miller DL, Bao S, Morris JE. Sonoporation of cultured cells in the rotating tube exposure system. Ultrasound Med Biol 1999;25:143-9.
16. Iwanaga K, Tominaga K, Yamamoto K, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007;14:354-63.
17. Larkin JO, Casey GD, Tangney M, et al. Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med Biol 2008;34:406-13.
18. Maeda H, Tominaga K, Iwanaga K, et al. Targeted drug delivery system for oral cancer therapy using sonoporation. J Oral Pathol Med 2009;38:572-9.
19. Sonoda S, Tachibana K, Uchino E, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 2007;6:1276-83.
20. Tomizawa M, Ebara M, Saisho H, et al. Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent. Cancer Lett 2001;173:31-5.
21. Tamosiunas M, Jurkonis R, Mir LM, et al. Adjustment of ultrasound exposure duration to microbubble sonodestruction kinetics for optimal cell sonoporation in vitro. Technol Cancer Res Treat 2012;11:375-87.
22. Escoffre J, Piron J, Novell A, Bouakaz A. Doxorubicin delivery into tumor cells with ultrasound and microbubbles. Mol Pharm 2011;8:799-806.
23. Venslauskas MS, Satkauskas S, Rodaite-Riseviciene R. Efficiency of the delivery of small charged molecules into cells in vitro. Bioelectrochemistry 2010;79:130-5.
24. Frich L, Halvorsen PS, Skulstad H, et al. Microbubbles in the pulmonary artery generated during experimental hepatic radio-frequency ablation is correlated with increased pulmonary arterial pressure. J Vasc Interv Radiol 2007;18:437-42.
25. Nishida M, Koito K, Hirokawa N, et al. Does contrast-enhanced ultrasound reveal tumor angiogenesis in pancreatic ductal carcinoma? A prospective study. Ultrasound Med Biol 2009;35:175-85.
26. Nomikou N, McHale AP. Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy. Cancer Lett 2010;296:133-43.
27. Liu Y, Yan J, Prausnitz MR. Can ultrasound enable efficient intracellular uptake of molecules? A retrospective literature review and analysis. Ultrasound Med Biol 2012;38:876-88.
28. Qiu Y, Zhang C, Tu J, Zhang D. Microbubble-induced sonoporation involved in ultrasound-mediated DNA transfection in vitro at low acoustic pressures. J Biomech 2012;45:1339-45.
29. Zhou Y, Yang K, Cui J, et al. Controlled permeation of cell membrane by single bubble acoustic cavitation. J Control Release 2012;157:103-11.
30. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005;104:213-22.
31. Meijering BD, Juffermans LJ, van Wamel A, et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 2009;104:679-87.
32. Geers B, Lentacker I, Alonso A, et al. Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded micro-bubbles. Mol Pharm 2011;8:2244-51.
33. Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 2006;112:149-55.
34. Haas EC, Zwart N, Meijer C, et al. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol 2008;26:1817-23.
35. Kamata Y, Itoh Y, Kajiya A, et al. Quantification of neutral cysteine protease bleomycin hydrolase and its localization in rat tissues. J Biochem 2007;141:69-76; Erratum in J Biochem (Tokyo) 2007;141:929.
36. Aouida M, Ramotar D. A new twist in cellular resistance to the anticancer drug bleomycin-A5. Curr Drug Metab 2010;11:595-602.
37. Liu S, Lai Y, Zhao W, et al. Links between DNA polymerase beta expression and sensitivity to bleomycin. Toxicology 2011;281:63-9.
38. Gac SL, Zwaan E, van den Berg A, Ohl CD. Sonoporation of suspension cells with a single cavitation bubble in a microfluidic confinement. Lab Chip 2007;7:1666-72.
39. Ohl CD, Arora M, Ikink R, et al. Sonoporation from jetting cavitation bubbles. Biophys J 2006;91:4285-95.
40. Browning RJ, Mulvana H, Tang MX, et al. Effect of albumin and dextrose concentration on ultrasound and microbubble mediated gene transfection in vivo. Ultrasound Med Biol 2012;38:1067-77.
41. Tang MX, Mari JM, Wells PN, Eckersley RJ. Attenuation correction in ultrasound contrast agent imaging: elementary theory and preliminary experimental evaluation. Ultrasound Med Biol 2008;34:1998-2008.
42. Delalande A, Bureau MF, Midoux P, et al. Ultrasound-assisted microbubbles gene transfer in tendons for gene therapy. Ultrasonics 2010;50:269-72.
43. Greis C. Technology overview: SonoVue (Bracco, Milan). Eur Radio 2004;14:11-15.
44. Krause W. Contrast agents II: optical, ultrasound, X-ray and radiopharmaceutical imaging. Berlin: Springer; 2002.